Features | n (%) | High expression (%) | Low expression (%) | P/χ2 value |
---|---|---|---|---|
Gender | 0.879/0.023 | |||
Male | 27 (77.6) | 13 (67.8) | 14 (32.2) | |
Female | 23 (22.4) | 10 (45.7) | 13 (54.3) | |
Age (year) | 0.653/0.365 | |||
≥60 | 23 (62.2) | 14 (60.8) | 9 (39.2) | |
<60 | 27 (37.8) | 13 (55.9) | 14 (44.1) | |
Tumor size (mm) | 0.012/10.054 | |||
≥50 | 28 (71.8) | 8 (71.4) | 20 (28.6) | |
<50 | 22 (28.2) | 14 (81.8) | 8 (18.2) | |
AFP (ng/mL) | 0.275/1.256 | |||
>400 | 23 (49.4) | 9 (45.5) | 14 (54.5) | |
<400 | 27 (50.6) | 13 (40.5) | 14 (59.5) | |
TNM stage | 0.027/12.864 | |||
T1 | 16 (35.9) | 11 (39.3) | 5 (60.7) | |
T2/T3 | 34 (64.1) | 16 (46.0) | 18 (54.0) | |
Intrahepatic metastasis status | 0.019/1.358 | |||
Positive | 15 (30.0) | 12 (80.0) | 3 (20.0) | |
Negative | 35 (70.0) | 18 (51.4) | 17 (48.6) | |
Tumor number | ||||
Single | 32 (64.0) | 14 (43.8) | 18 (56.2) | 0.504/9.281 |
Two or more | 18 (36.0) | 8 (44.4) | 10 (55.6) |